Researchers from Cyprus have developed a rapid, noninvasive diagnostic for Down syndrome that detects methylated fetal DNA in the blood of pregnant women. New company NIPD Genetics hopes to use the method to develop a test that is cheaper than sequencing techniques used by Sequenom and Artemis Health.